Table 3:
Local adverse events according to the pattern of IAC drug delivery
| Adverse Events (No.) (%) | FPO | FPEC | VP |
|---|---|---|---|
| Transient | |||
| Palpebral edema/hyperemia, 55 (55.6%) | 40 | 6 | 9 |
| Frontal edema/hyperemia, 14 (14.1%) | 10 | 1 | 3 |
| Retinal bleeding, 12 (12.1%) | 10 | 0 | 2 |
| Anterior ischemia of the optic nerve, 2 (2%) | 1 | 0 | 1 |
| Madarosis, 2 (2%) | 2 | 0 | 0 |
| Frontal alopecia, 2 (2%) | 1 | 0 | 1 |
| Orbital cellulitis, 1 (1%) | 1 | 0 | 0 |
| Glaucoma, 1 (1%) | 0 | 0 | 1 |
| Roth spots, 1 (1%) | 1 | 0 | 0 |
| Iridocyclitis, 1 (1%) | 1 | 0 | 0 |
| Permanent | |||
| Chorioretinic atrophy, 16 (16.2%) | 13 | 2 | 1 |
| Exotropia, 4 (4%) | 2 | 2 | 0 |
| Ptosis, 1 (1%) | 1 | 0 | 0 |
| Anisocoria, 1 (1%) | 0 | 0 | 1 |
| Cutaneous scar necrosis, 1 (1%) | 0 | 1 | 0 |
| Iris heterochromia, 1 (1%) | 0 | 0 | 1 |